Form 4: STERIS plc Executive Julia Madsen Reports Share Transaction
SEC Form 4 Filing
Senior VP Julia Madsen of STERIS plc reports the withholding of 207 shares for tax obligations following the vesting of restricted shares.
Summary
- On May 31, 2024, Julia Madsen, Senior VP of Life Sciences at STERIS plc, reported a transaction involving ordinary shares.
- 207 shares were withheld to cover tax obligations related to the vesting of 578 restricted shares.
- The withheld shares were valued at $222.88 each, based on the NYSE closing market price on May 31, 2024.
- Following the transaction, Ms. Madsen beneficially owns 8,344 ordinary shares, with 3,692 of these shares being restricted.
- The restrictions on these ordinary shares lapse at various dates in June and October of 2024, 2025 and 2026.
- Ms. Madsen has granted a power of attorney to several authorized representatives, including Ronald E. Snyder, to handle SEC filings related to STERIS plc securities.
Sentiment
Score: 7
Explanation: The document reflects standard executive compensation practices and compliance with SEC regulations, indicating a neutral to slightly positive sentiment.
Industry Context
This is a routine disclosure related to executive compensation and share ownership, common for publicly traded companies.
Stakeholder Impact
- The transaction has a minimal direct impact on stakeholders, as it primarily concerns executive compensation and tax obligations.
Key Dates
| Date | Description |
|---|---|
| October 31, 2023 | Date of Power of Attorney authorization |
| May 31, 2023 | Date Ms. Madsen was awarded 578 ordinary shares. |
| May 31, 2024 | Date of share transaction and vesting of restricted shares. |
| May 31, 2024 | Date of NYSE closing market price used to value shares. |
| June 3, 2024 | Date restrictions lapse on 352, 123 and 360 ordinary shares. |
| June 2, 2025 | Date restrictions lapse on 578, 352 and 360 ordinary shares. |
| June 1, 2026 | Date restrictions lapse on 578 ordinary shares. |
| June 2, 2026 | Date restrictions lapse on 352 ordinary shares. |
| October 1, 2024 | Date restrictions lapse on 349 and 144 ordinary shares. |
| October 1, 2025 | Date restrictions lapse on 144 ordinary shares. |
| June 4, 2024 | Date of signature for the report. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.